Ryan Schuler, Senior Managing Director, Ascension Ventures (AV). Since joining AV in 2002, Ryan has led AV’s investments in Aethon, Bind, Comprehensive Pharmacy Services, Haven Behavioral, Help at Home, Impulse Monitoring, Mindpath Health, NaviHealth, SeQual Technologies, Sevita, Solstas Lab Partners, SterilMed and The Ob Hospitalist Group. Previously, Ryan worked at A.G. Edwards in the mergers and acquisitions investment banking group and PricewaterhouseCoopers in the transaction support and audit practices. Ryan earned his MBA from Washington University and his BS from Christian Brothers University.
AV has invested in over 80 services, software, and medical device / diagnostic companies that help health systems on their transformation journeys. AV is a stage-agnostic investor seeking companies that meet the high priority needs of its health system partners and their patients. AV brings the voice of the customer to its portfolio companies and advises their management teams on product, sales, marketing and financing strategies. AV measures success by financial returns to its partners and strategic value delivered to partners and portfolio companies. Many of the companies backed by AV have had their offerings adopted by AV’s health system partners and ultimately progressed to successful exits.
In March 2021, Ascension Ventures announced the closing of its fifth strategic fund (a $285 million vehicle) which brings the firm’s total assets under management to more than $1 billion. The new fund is backed by 13 leading health system partners directly involved in AV’s diligence and investment approval process. Joining Ascension as limited partners in the new fund are continuing health system partners AdventHealth, Carle Foundation, CentraCare, Children’s Medical Center of Dallas, Intermountain Healthcare, Novant Health, OhioHealth and OSF HealthCare. New limited partners in the fund include Luminis Health, NorthShore, Sentara Healthcare, and Texas Health Resources.
Bio posted January 2022